Stephen M Lynch, Laykea Tafesse, Kevin Carlin, Parijat Ghatak, Donald J Kyle
Index: Bioorg. Med. Chem. Lett. 25(1) , 43-7, (2015)
Full Text: HTML
We have identified two related series of dibenzazepine and dibenzoxazepine sodium channel blockers, which showed good potency on Nav1.7 in FLIPR-based and electrophysiological functional assays.